JAK1 and posterior cortical atrophy: As EHDV-TAU successfully kills IL-6-treated LNCaP-JAK1 cells, which express JAK1 and STAT1/3 target genes, we interrogated [with cBioPortal (69)] gene expression in patient-derived metastatic PCa samples (70).